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We describe a simplified method for the in vitro synthesis of mutated RNA molecules. The method makes 
use of an oligodeoxyribonucleotide (?I’,-oligo) which contains the T7 RNA polymerase promoter sequence. 
In combination with a second oligonucleotide, a series of transcripts initiating and terminating at any chosen 
position on a cloned ss DNA (e.g. Ml3 phage DNA) can be generated. The phage DNA represents the 
non-coding DNA strand for the desired transcript; the Tr-oligo determines the transcription start site, 
whereas the second oligonucleotide permits the choice of the transcription termination site. The synthesis 
of the required template DNA is achieved by hyb~~~ng the two oligonucl~tides to the phage DNA and 
subsequently synthesizing the coding DNA strand by a fill-in reaction with Klenow enzyme. The reaction 
product is used directly as a template for Tr RNA polymerase; cloning of mutants is not required. 
T7 RNA polymerase; Transcription; Oligonucleotide promoter 
1. INTRODUCTION 
The very specific RNA polymerases from the 
bacteriophages T7 and SP6 [ 1,2] are available com- 
mercially in highly purified form. This allows the 
facile in vitro synthesis of RNA from cloned ex- 
pression plasmids 121. The ability to generate RNA 
molecules has greatly facilitated studies of RNA 
processing 23-71. RNA synthesis from engineered 
DNA plasmids is a very powerful but labour- 
intensive approach, especially if a series of trun- 
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cated RNAs is to be analyzed for lost or retained 
function [6]. Such expression plasmids are derived 
from vectors which contain a polylinker down- 
stream of an RNA polymerase promoter. Fre- 
quently subcloning of the gene of interest into 
these vectors requires the cumbersome ngineering 
of new restriction sites which allow the choice of 
start and end of the transcript. However, these 
manipulations may result in unwanted sequence 
changes. In addition, the transcripts contain the 
5 ’ -terminal stretch of the vector sequence located 
between the promoter and polylinker. 
Here we describe the use of an oligonucleotide 
promoter (TT-oligo) which circumvents these 
problems. In combination with a second 
oligonucleotide (terminator oligo) this method 
allows the precise initiation and termination of 
transcription at any point in the cloned DNA and 
avoids the tedious construction, characterization 
and subcloning of mutants. 
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2. EXPERIMENTAL 
2.1. 3 ‘-addition of ddA to the promoter 
oligonucleotide 
1 nmol of the promoter oligonucieotide 
(-20 pg) was incubated for 30 min at 25OC in 50 ~1 
containing 7 mM Tris-HCl (pH 7.5), 7 mM 
MgC12, 50 mM NaCl, 0.1 mM ddATP and 20 U 
Klenow enzyme. The ddA-extended oligo- 
nucleotide (T,-oligo) was purified on a denaturing 
20% polyacrylamide gel. 
2.2. Synthesis of template DNA 
In order to permit analysis of the synthesized 
DNA, 32P-dATP was included in this protocol, 
whereas RNA transcripts were obtained from 
unlabeled DNA. The Ml3 phage DNA used in this 
report contained a 3.4 kb EcoRI fragment of the K 
RNA gene cloned into M13mp9 [4]. 1 gg 
M13mp9K phage DNA (-0.3 pmol), 100 ng 
5 ’ -phosphorylated TT-oligo (-4.5 pmol) and 3 ng 
of the gene specific terminator oligo GK29 
(-0.3 pmol; the ‘universal’ or any appropriate 
primer can also be used) were annealed in lop1 
containing 14 mM Tris-HCl (pH 7.5), 14 mM 
MgC12, 100 mM NaCl, followed by incubation for 
60 min at 25°C with 50pM of each deoxy- 
nucleoside triphosphate, 0.5 pCi [cu-32P]dATP, 
0.5 mM ATP, 0.5 mM DTT and 1 U Klenow en- 
zyme (BRL) and 1 U DNA ligase (Promega) in a 
final reaction volume of 20~1. Then the sample 
was heated for 5 min at 65°C. 
Analysis of the reaction products by elec- 
trophoresis (8% denaturing polyacrylamide gel) 
and autoradiography showed that about 20% of 
the theoretical yield of template DNA with the ex- 
pected size was obtained. Most of the product was 
material with a high molecular mass (not shown). 
2.3. Transcription reactions 
The synthesized template DNA was used directly 
or after restriction endonuclease cleavage. Non- 
radioactive template DNA was used. Removal of 
excess T7-oligo was not necessary as no improved 
tr~scription efficiency was observed after gel elec- 
trophoretic purification (not shown). The material 
obtained from 0.2ag Ml3 phage DNA was in- 
cubated in 10 yl of 40 mM Tris-HCI (pH 7.5), 
6 mM MgC12, 2 mM spermidine, 10 mM NaCl, 
10 mM DTT, 5OOhM NTPs (ATP, CTP, UTP), 
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20,~M [w~~P]GTP (50 Ci/mmol) with 40 U T7 
RNA polymerase (BRL) for 60 min at 37°C. After 
phenol extraction, excess label was removed by 
ethanol precipitation from 2 M ammonium acetate 
(pH 7) and the product was analyzed on a denatur- 
ing 8% polyacryl~ide gel. 
5 ‘-end labeled RNA for the identi~cation of the 
initiating nucleoside was obtained by transcription 
in the presence of 100 PM [y-32P]ATP 
(200 CVmmol). 
3. RESULTS 
3.1. Synthesis of the template DNA for T? RNA 
po~ymer~e 
Transcription by T, RNA polymerase is well 
understood in terms of its promoter sequence and 
RNA initiation site [I]. Here we describe a method 
which utilizes these two features to direct 
transcription initiation at practically any predeter- 
mined sequence within a cloned DNA. The method 
has two steps: (i) the construction of the template 
DNA consisting of the desired sequence linked to 
an oligonucleotide containing the T7 RNA 
polymerase promoter sequence (TT-oligo); (ii) the 
transcription of the template DNA. 
After choosing the DNA sequence to be 
transcribed (e.g., from a cloned DNA fragment in 
Ml3 phage) the T,-oligo needs to be synthesized. 
This oiigonu~leotide (fig. 1) combines the constant 
promoter sequence (as ds DNA in a hairpin) with 
a variable ss domain which is complementary to 
the ss phage DNA at the point where transcription 
should initiate. In principle, the ss domain could 
be at either end of the T7-oligo. However, good 
transcription results were obtained only if the ss 
domain was at the 5 ’ -end of the TT-oligo, thus en- 
coding a short segment of the 5 ’ -terminal sequence 
of the desired transcript (fig.1). 
The full size template DNA is synthesized in 
vitro, using the TT-oligo in combination with a 
second oligonucleotide (terminator oligo). The 
complete sequence of the desired transcript is pre- 
sent in the phage DNA segment (non-coding 
strand) whose ends are defined by the two 
hybridized oligonu~leotides (coding strand) as 
shown in fig.2. The complete coding DNA strand 
is obtained by primer extension of the terminator 
oligo with Klenow enzyme, closing the gap bet- 
ween the two hybridized oligonucleotides. In the 
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Fig.1. Sequence of the synthetic oligodeoxyribo- 
nucleotide (T-I-oligo). The Tf promoter [I] is boxed. The 
encoded transcript is shown in lower ease letters. The 
arrowhead indicates the suggested ligation point of a 
shortened TT-oligo (‘portable promoter’) with a gene- 
specific oligonucleotide (see section 4). 
presence of DNA ligase the synthesized DNA is 
joined to the 5 ‘-phospho~lated T,-oligo (fig.2). It 
is impo~~t to block the extension of the T7-ohgo 
by prior introduction of ddA at its 3’ -end [8] (see 
section 2.1). Otherwise the ss domain would be 
converted to ds DNA and would no longer be 
available for hybridization to Ml3 DNA. The 
resulting template DNA contains the T7 promoter 
sequence in a hairpin structure (i.e. as ds DNA), 
joined to the in vitro synthesized coding strand for 
the desired transcript (fig.2). This constrnct, still 
hybridized to the phage DNA, can be used directly 
as a template for transcription. 
The method was tested in the experiment shown 
in fig.?). Transcription was expected to initiate 
precisely at the first nucieotide in the ss domain of 
the T7-oligo (fig. 1) and terminate at the end of the 
synthesized DNA. Thus, the 3’-terminal 
nucleotide of the transcript is encoded by the 
5’-terminal nucleotide of the terminator oligo 
(GK29). Alternatively, the standard protocol for 
the termination of run-off transcription can be 
used, so that cleavage of the DNA by a convenient 
restriction endonuclease determines the 3 ’ -end of 
the transcript (TaqI and &a1 in fig.3). 
3.2. The transcription initiation site is determined 
precisely by the Troligo 
In order to confirm that the predicted transcrip- 
Fig.3. A specific example of RNA synthesis. For details 
see text. Ml3 DNA (thick line) containing an inserted 
DNA fragment (thin line) is shown. The synthesized 
template DNA is represented as a broken line. 
Restriction sites are marked and the lengths and 
orientations of the expected transcripts are indicated. If
cloning of the template DNA is desired, an extended 
TT-oligo is used, which inchrdes the indicated PstI 
recognition sequence (not present in the TT-oligo shown 
in fig.1). PstI will be used to generate a ss DNA 
fragment which is converted to ds DNA by primer- 
extension of ligonucl~tide A (for details ee section 4). 
* 
3. Transcrlptlon 
with T7 RNA 
polymerase 
Fig.2. Scheme for the synthesis of the template DNA for T7 RNA polymerase transcriptions. The arrowheads indicate 
the 3’-ends of terminator oligo and RNA transcript. 
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tion initiation site was actually used, the size of 
two short transcripts was determined. The syn- 
thesized template DNA was cleaved with RsaI or 
TaqI (converted to blunt-ends with Klenow en- 
zyme) and the subsequent ranscription reactions 
yielded the expected RNAs of 107 or 37 nucleotide 
length, respectively (figs 3, 4A, 4B). In addition, 
the 5 ‘-terminal nucleoside was identified. As in- 
dicated in fig.1, initiation with an adenosine 
residue was expected. Accordingly, internal la- 
beling with [~u-~~P]GTP, or labeling of only the in- 
itiating nucleotide with [Y-~~P]ATP resulted in 
transcripts of the same size (fig.4). 
3.3. Oligonucleotides allow precise initiation and 
termination of RNA synthesis 
As reported by Eperon [9], oligonucleotides per- 
mit transcription termination at a predetermined 
site. In his approach, however, the ss phage DNA 
already contains the T7 RNA polymerase promoter 
sequence, covalently joined to the non-coding 
strand for the desired transcript. This phage DNA 
is derived from mICE 191, Bluescribe or similar 
vectors. A terminator oligo hybridizes to the DNA 
where transcription should terminate; the coding 
strand is synthesized by primer extension with 
Klenow enzyme. In these constructs primed DNA 
synthesis is extended beyond the promoter se- 
quence, which assures that the promoter is present 
as ds DNA. This is mandatory for the recognition 
by RNA polymerase [l]. However, it should be 
noted that the coding DNA strand itself can be 
used in ss form. The isolated T-I-oligo codes for a 
short transcript (indicated in fig.l), which can be 
synthesized with T7 RNA polymerase (not shown). 
The TT-oligo directed transcription initiation 
described above was combined with oligo- 
nucleotide-directed transcription termination. As 
the terminator oligo (see section 3.1), the gene 
specific oligonucleotide GK29 was used as the 
primer in template DNA synthesis (fig.3). The ob- 
tained DNA construct was not cleaved with restric- 
tion endonucleases and transcription terminated at 
the expected site (fig.3): a 297 nucleotide long 
RNA was synthesized by T7 RNA polymerase 
(fig.4C); -90000 cpm from 0.2,~g ss Ml3 DNA 
(-10 kb). 
This amount of labeled RNA corresponds to 
about 10% of the yield obtained under similar con- 
ditions with a standard DNA template, i.e. 0.2 pg 
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Fig.4. Analysis of the transcripts. Panels A and B: run- 
off transcripts from Z&I and TuqI cleaved template 
DNA, respectively. Panel C: product of GK29-directed 
transcription termination. Lanes: 1,2, transcripts with 
[T-‘~P]ATP or [~u-‘~P]GTP, respectively; Tr, H, size 
markers obtained from a 5’-32P-labeled run-off 
transcript (linearized pGem3 derivative as template) 
after RNase Tr or acid cleavage [4]; M, 301 nucleotide 
run-off transcript as size marker. 
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linearized expression plasmid (-3.5 kb). However, 
only about 20% of the Ml3 phage DNA used was 
converted to ds template DNA (section 2.2). This 
means that the amount of transcript synthesized 
may reach up to 50% of the value obtained, if 
compared to the same molar amount of standard 
expression plasmid. 
In addition to the expected product, undefined 
large RNAs were also synthesized (fig.4C, lane 2). 
This is a common problem if ds DNA with a 
3 ‘-protruding end is used as a template for RNA 
polymerases and was also observed in 
oligonucleotide-directed transcription termination 
([9] and Eperon, I.C., personal communication). 
4. DISCUSSION 
Our method for the simplified in vitro synthesis 
of mutated RNA molecules is based on the use of 
an oligonucleotide hairpin structure, which serves 
as a promoter for T7 RNA polymerase. In another 
example for the use of self-complementary 
oligonucleotides, it was possible to ‘place’ a 
restriction enzyme recognition site at any position 
in a particular DNA sequence [lo]. 
Our scheme has several advantages over the 
more conventional cloning and subcloning of 
engineered expression plasmids. (i) RNAs which 
begin and end at any chosen point of a cloned 
DNA fragment are easily available. (ii) The 
chemical synthesis of oligodeoxyribonucleotides 
which are to be incorporated into the coding DNA 
strand allows the easy introduction of point muta- 
tions near both termini of the RNA transcript. (iii) 
The requirements for oligonucleotide synthesis are 
not excessive, since the long hairpin structure con- 
taining the T7 RNA polymerase promoter is syn- 
thesized only once (‘portable promoter’) and can 
be ligated to any gene-specific oligonucleotide (see 
arrow in fig.1). 
However, if a particular construct is needed fre- 
quently, cloning into a convenient vector may be 
preferable. For this purpose the extended TT-oligo 
is used. It contains a PstI recognition site in the ds 
hairpin (indicated in fig.3). The 32P-labeled 
template DNA is synthesized as described (see sec- 
tions 2.2 and 3.1) and cut with PstI. Then the 
labeled ss DNA fragment is isolated after denatur- 
ing gel electrophoresis. After annealing with 
oligonucleotide A (fig.3; without 3 ’ -terminal 
ddA), primer extension with reverse transcriptase 
is possible. Reverse transcriptase is required 
because it lacks a 3 ’ -5 ’ -exonuclease activity [ 111. 
Thus the 3 ’ -protruding end generated by PstI is re- 
tained in the newly generated ds DNA fragment. 
This allows convenient cloning into an appropriate 
vector for large scale preparations of plasmid con- 
taining the template DNA insert. 
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